Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1T38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,847
Award facts
- Contract value 100% obligated
- $25,846.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,846.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Dupixent 300 mg/2 mL pens. This is a non-set-aside competitive award with a completion date of January 8, 2026, and performance fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Department of Defense and military healthcare systems. The company's contract portfolio encompasses a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals across multiple therapeutic domains. This delivery order for Dupixent, a biologics medication used in the treatment of eczema, asthma, and other inflammatory conditions, reflects the company's ongoing role in supplying specialized pharmaceutical products to support the Defense Health Agency and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1T38?
SPE2DR26F1T38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F1T38 worth?
The government has obligated $25,847 on SPE2DR26F1T38.
Is contract SPE2DR26F1T38 an order under another contract?
Yes. SPE2DR26F1T38 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T38 competed?
The extent of competition for SPE2DR26F1T38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award